BICO Group AB (publ)

OM:BICO Stock Report

Market Cap: SEK 2.5b

BICO Group Valuation

Is BICO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BICO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
SEK 41.36
Fair Value
13.3% undervalued intrinsic discount
3
Number of Analysts

Below Fair Value: BICO (SEK35.86) is trading below our estimate of fair value (SEK41.36)

Significantly Below Fair Value: BICO is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BICO?

Key metric: As BICO is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BICO. This is calculated by dividing BICO's market cap by their current revenue.
What is BICO's PS Ratio?
PS Ratio1.3x
SalesSEK 1.95b
Market CapSEK 2.53b

Price to Sales Ratio vs Peers

How does BICO's PS Ratio compare to its peers?

The above table shows the PS ratio for BICO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.5x
GENO Genovis AB (publ.)
8.9x10.1%SEK 1.3b
MCAP MedCap
3.2x12.9%SEK 5.8b
BIOT Biotage
3.5x5.9%SEK 7.2b
MAGLE Magle Chemoswed Holding
2.2x12.7%SEK 586.8m
BICO BICO Group
1.3x7.2%SEK 2.5b

Price-To-Sales vs Peers: BICO is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (4.5x).

Price to Sales Ratio vs Industry

How does BICO's PS Ratio compare vs other companies in the European Life Sciences Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
BICO 1.3xIndustry Avg. 3.9xNo. of Companies9PS02.85.68.411.214+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: BICO is good value based on its Price-To-Sales Ratio (1.3x) compared to the European Life Sciences industry average (3.9x).

Price to Sales Ratio vs Fair Ratio

What is BICO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BICO PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.3x
Fair PS Ratio2.3x

Price-To-Sales vs Fair Ratio: BICO is good value based on its Price-To-Sales Ratio (1.3x) compared to the estimated Fair Price-To-Sales Ratio (2.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BICO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 35.86
SEK 64.67
+80.3%
23.3%SEK 85.00SEK 49.00n/a3
Apr ’26SEK 31.06
SEK 64.67
+108.2%
23.3%SEK 85.00SEK 49.00n/a3
Mar ’26SEK 36.64
SEK 75.00
+104.7%
20.0%SEK 90.00SEK 60.00n/a2
Feb ’26SEK 33.38
SEK 95.00
+184.6%
5.3%SEK 100.00SEK 90.00n/a2
Nov ’25SEK 39.16
SEK 102.50
+161.7%
2.4%SEK 105.00SEK 100.00n/a2
Oct ’25SEK 43.10
SEK 102.50
+137.8%
2.4%SEK 105.00SEK 100.00n/a2
Sep ’25SEK 44.54
SEK 120.00
+169.4%
12.5%SEK 135.00SEK 105.00n/a2
Aug ’25SEK 40.76
SEK 120.00
+194.4%
12.5%SEK 135.00SEK 105.00n/a2
Jul ’25SEK 44.40
SEK 120.00
+170.3%
12.5%SEK 135.00SEK 105.00n/a2
Jun ’25SEK 44.82
SEK 132.50
+195.6%
1.9%SEK 135.00SEK 130.00n/a2
May ’25SEK 46.30
SEK 132.50
+186.2%
1.9%SEK 135.00SEK 130.00n/a2
Apr ’25SEK 47.20
SEK 132.50
+180.7%
1.9%SEK 135.00SEK 130.00SEK 31.062
Sep ’24SEK 43.96
SEK 132.50
+201.4%
1.9%SEK 135.00SEK 130.00SEK 44.542
Aug ’24SEK 41.45
SEK 132.50
+219.7%
1.9%SEK 135.00SEK 130.00SEK 40.762
Jul ’24SEK 39.01
SEK 132.50
+239.7%
1.9%SEK 135.00SEK 130.00SEK 44.402
Jun ’24SEK 53.78
SEK 132.50
+146.4%
1.9%SEK 135.00SEK 130.00SEK 44.822
May ’24SEK 61.22
SEK 132.50
+116.4%
1.9%SEK 135.00SEK 130.00SEK 46.302
Apr ’24SEK 54.18
SEK 132.50
+144.6%
1.9%SEK 135.00SEK 130.00SEK 47.202
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
SEK 64.67
Fair Value
44.5% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/17 20:56
End of Day Share Price 2025/04/17 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BICO Group AB (publ) is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dylan van HaaftenBryan Garnier & Co
Hanseung YooBryan Garnier & Co
Maria Vara FernándezBryan Garnier & Co